Stem cell therapies for Parkinson’s disease: are trials just around the corner?

Written by Regenerative Medicine

Free to access editorial from our latest Regenerative Medicine issue by Janelle Drouin-Ouellet and Roger A Barker What types of stem cells are being considered for use in PD? Stem cells, by definition, have the inherent ability to differentiate into any cell type of the human body. They can either be sourced from embryos (embryonic stem cells; ESCs), a variety of differentiated tissues (adult stem cells) or generated from a source of adult somatic cells (induced pluripotent stem cells; iPSCs). All of these sources are being considered for cell-based therapies for PD, but the most advanced work is currently being...

To view this content, please register now for access

It's completely free